Indian drug makers are finding themselves under the gun as run-ins with global drug regulators are on the rise. This is being seen as a golden opportunity by Merck Millipore, the life sciences division of German drug maker Merck, which also works on setting up high quality drug manufacturing processes, reports Archana Shukla.
first published: Jan 8, 2015 09:51 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Tests 25,900 But Stages Smart Recovery From Day's Low | Closing Bell Live | 4K
The Bihar conundrum- freebies Vs Growth with NK Singh, Economist and Former MP
Will Nifty Cross 26,100 Hurdle On Weekly F&O Expiry? PhysicsWallah Lists Today|Opening Bell Live
How SIP Top-Ups Can Boost Your Wealth | Smart Investing Made Simple
